What happens during a C&P exam for Hyperaldosteronism (Conn's Syndrome)?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

← All Condition Guides

CLAIM RECON INTEL

Hyperaldosteronism (Conn's Syndrome)

Q: What are the VA rating percentages for Hyperaldosteronism (Conn's Syndrome)?

Hyperaldosteronism (Conn's Syndrome) (DC 7917) is rated at 100%, 0% under 38 CFR § 4.119, DC 7911. When the underlying neoplasm is malignant (rare adrenocortical carcinoma producing aldosterone), DC 7914 verbatim — 100% during/after surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure; mandatory VA examination at six months; any rating change subject to § 3.105(e); if no recurrence or metastasis, rate-as residuals of endocrine dysfunction (hypertension under DC 7101, hypokalemia, cardiac sequelae).

Q: What rates 100% for Hyperaldosteronism (Conn's Syndrome) under 38 CFR § 4.119, DC 7911?

Under 38 CFR § 4.119, DC 7911 (DC 7917), a 100% rating for Hyperaldosteronism (Conn's Syndrome) requires: When the underlying neoplasm is malignant (rare adrenocortical carcinoma producing aldosterone), DC 7914 verbatim — 100% during/after surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure; mandatory VA examination at six months; any rating change subject to § 3.105(e); if no recurrence or metastasis, rate-as residuals of endocrine dysfunction (hypertension under DC 7101, hypokalemia, cardiac sequelae).

Q: What rates 0% for Hyperaldosteronism (Conn's Syndrome) under 38 CFR § 4.119, DC 7911?

Under 38 CFR § 4.119, DC 7911 (DC 7917), a 0% rating for Hyperaldosteronism (Conn's Syndrome) requires: Evaluate as a malignant (DC 7914) or benign (DC 7915) endocrine neoplasm, as appropriate. Most cases — Conn's syndrome from a benign aldosterone-producing adrenal adenoma — are rated under DC 7915, with the disability rated entirely on the basis of the resulting dysfunction (hypertension under § 4.104, DC 7101; hypokalemia and its consequences; muscle weakness; cardiac sequelae). Adrenocortical carcinoma producing aldosterone follows DC 7914 (100% during/after active treatment; mandatory VA exam at 6 months; rating change subject to § 3.105(e)).

Q: What evidence do I need for a Hyperaldosteronism (Conn's Syndrome) VA claim?

Key evidence for a Hyperaldosteronism (Conn's Syndrome) claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 791738 C.F.R. § 4.119

Diagnostic Code

DC 7917

38 C.F.R. § 4.119

Rating Range

0–100%

2 severity tiers

Source

Verified

38 C.F.R. § 4.119

Hyperaldosteronism (Conn's Syndrome) is rated by the U.S. Department of Veterans Affairs under DC 7917 of 38 CFR § 4.119, DC 7911 across 2 severity tiers (100% / 0%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Overproduction of aldosterone by the adrenal glands, leading to high blood pressure and low potassium levels. Conn's syndrome refers to the primary form caused by an adrenal adenoma.

Rating Criteria

100%

When the underlying neoplasm is malignant (rare adrenocortical carcinoma producing aldosterone), DC 7914 verbatim — 100% during/after surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure; mandatory VA examination at six months; any rating change subject to § 3.105(e); if no recurrence or metastasis, rate-as residuals of endocrine dysfunction (hypertension under DC 7101, hypokalemia, cardiac sequelae).

Evaluate as a malignant (DC 7914) or benign (DC 7915) endocrine neoplasm, as appropriate. Most cases — Conn's syndrome from a benign aldosterone-producing adrenal adenoma — are rated under DC 7915, with the disability rated entirely on the basis of the resulting dysfunction (hypertension under § 4.104, DC 7101; hypokalemia and its consequences; muscle weakness; cardiac sequelae). Adrenocortical carcinoma producing aldosterone follows DC 7914 (100% during/after active treatment; mandatory VA exam at 6 months; rating change subject to § 3.105(e)).

03Key Evidence

—Service treatment records showing injury or complaints

—Imaging (X-ray, MRI, CT)

—Range of motion measurements

—Flare-up documentation per Sharp v. Shulkin

—Buddy statements describing limitations

—Prescription history

—Physical therapy records

—Employment impact documentation

04C&P Exam Tips

1Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5If you use assistive devices (brace, cane), bring them.

6Describe daily activity impact: work, sleep, household tasks.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.119 (Endocrine system). Source verified 2026-05-15 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.119 on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING